Diabetes prone BB rats are severely deficient in natural killer T cells

Autoimmunity

Volumn 31, Issue 1, 1999, Pages 1-14

  Iwakoshi, Neal N ^a   Greiner, Dale L ^a   Rossini, Aldo A ^a   Mordes, John P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; BB rat; Diabetes; Intrahepatic lymphocytes; NK T cell

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; RAT; SPLEEN LYMPHOCYTE; T LYMPHOCYTE;

EID: 0033278096     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908993854     Document Type: Article

References (42)

1. J.P. Mordes, D.L. Greiner and A.A. Rossini. Animal models of autoimmune diabetes mellitus. In: LeRoith, D., Taylor, S.I. and Olefsky, J.M., eds. Diabetes Mellitus. A Fundamental and Clinical Text. Philadelphia: Lippincott-Raven, 1996; pp. 349-360.
2. D.L. Guberski. Diabetes-prone and diabetes-resistant BB rats: Animal models of spontaneous and virally induced diabetes mellitus, lymphocytic thyroiditis, and collagen-induced arthritis. ILAR News 1994; 35: 29-37.
3. L. Crisá, J.P. Mordes and A.A. Rossini. Autoimmune diabetes mellitus in the BB rat. Diabetes/Metab. Rev. 1992; 8: 9-37.
4. R. Bortell, T. Kanaitsuka, L.A. Stevens, J. Moss, J.P. Mordes, A.A. Rossini et al. The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse. Mol. Cell. Biochem. 1999; 193: 61-68.
5. J.P. Mordes, R. Bortell, J. Doukas, M.R. Rigby, B.J. Whalen, D. Zipris et al. The BB/Wor rat and the balance hypothesis of autoimmunity. Diabetes/Metab. Rev. 1996; 2: 103-109.
6. N.N. Iwakoshi, I. Goldschneider, F. Tausche, J.P. Mordes, A.A. Rossini and D.L. Greiner. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes prone BioBreeding rats. J. Immunol. 1998; 160: 5838-5850.
7. K. Wonigeit, A. Dinkel, J. Fangmann and H. Thude. Expression of the ectoenzyme RT6 is not restricted to resting peripheral T cells and is differently regulated in normal peripheral T cells, intestinal IEL, and NK cells. Adv. Exp. Med. Biol. 1997; 419: 229-240.
8. A. Bendelac, M.N. Rivera, S.H. Park and J.H. Roark. Mouse CD1-specific NK1 T cells: Development, specificity, and function. Ann. Rev. Immunol. 1997; 15: 535-562.
9. + T cells: A new family of T cells. Immunol. Today 1996; 17: 71-76.
10. + T-cell deficiency and IDDM in NOD/L1 mice. Diabetes 1997; 46: 572-582.
11. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 1997; 159: 2240-2249.
12. J. Cui, T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-1626.
13. + -like thymocytes in the NOD mouse. Eur. J. Immunol. 1996; 26: 2989-2998.
14. K. Takeda and G. Dennert. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: Evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med. 1993; 177: 155-164.
15. + NK T cells associated with disease development in autoimmuneprone mice. J. Immunol. 1996; 156: 4035-4040.
16. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998; 187: 1047-1056.
17. D. Zeng, M. Dick, L. Cheng, M. Amano, S. Dejbakhsh-Jones, P. Huie et al. Subsets of transgenic T cells that recognize CDI induce or prevent murine lupus: Role of cylokines. J. Exp. Med. 1998; 187: 525-536.
18. C. Prussin, and B. Foster. TCR Valpha24 and Vbetall coexpression defines a human NKT cell analog containing a unique ThO subpopulation. J. Immunol. 1997; 159: 5862-5870.
19. S.B. Wilson, S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177-181.
20. C. Brissette-Storkus, C.L. Kaufman, L. Pasewicz, H.M. Worsey, R. Lakomy, S.T. Ildstad et al. Characterization and function of the NKR-P1dim/T cell receptor-alpha beta+subset of rat T cells. J. Immunol. 1994; 152: 388-396.
21. + T cells: Selective proliferation in interleukin-2, diverse T-cell-receptor-Vβ repertoire and polarized interferon-gamma expression. Immunology 1998; 95: 117-125.
22. B.J. Whalen, A.A. Rossini, J.P. Mordes and D.L. Greiner. DR-BB rat thymus contains thymocyte populations predisposed to autoreactivity. Diabetes 1995; 44: 963-967.
23. W.H. Chambers, N.L. Vujanovic, A.B. DeLeo, M.W. Olszowy, R.B. Herberman and J.C. Hiserodt. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J. Exp. Med. 1989; 169: 1373-1389.
24. P. Kuhnlein, J.H. Park, T. Herrmann, A. Elbe and T. Hunig. Identification and characterization of rat gamma/delta T lymphocytes in peripheral lymphoid organs, small intestine, and skin with a monoclonal antibody to a constant determinant of the gamma delta T cell receptor. J. Immunol. 1994; 153: 979-986.
25. P.C. O'Brien and M.A. Shampo. Statistical considerations for performing multiple comparisons in a single experiment. 2. Comparisons among multiple therapies. Mayo Clin. Proc. 1988; 63: 816-820.
26. B.A. Woda and C.A. Biron. Natural killer cell number and function in the spontaneously diabetic BB/W rat. J. Immunol. 1986; 137: 1860-1866.
27. + subset. Cell. Immunol. 1988; 114: 336-346.
28. + T cells. Develop. Immunol. 1991; 1: 191-201.
29. R. Galandrini, R. De Maria, M. Piccoli, L. Frati and A. Santoni. CD44 triggering enhances human NK cell cytotoxic functions. J. Immunol. 1994; 153: 4399-4407.
30. G. Sconocchia, J.A. Titus and D.M. Segal. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J. Immunol. 1994; 153: 5473-5481.
31. H. Groen, F.A. Klatter, N.H.C. Brons, A.S. Wubbena, P. Nieuwenhuis and J. Kampinga. High-frequency, but reduced absolute numbers of recent thymic migrants among peripheral blood T lymphocytes in diabetes-prone BB rats. Cell. Immunol. 1995; 163: 113-119.
32. + cells. J. Immunol. 1990; 144: 923-928.
33. H.H. Zadeh, D.L. Greiner, D.Y. Wu, F. Tausche and I. Goldschneider, Abnormalities in the export and fate of recent thymic emigrants in diabetes-prone BB/W rats. Autoimmunity 1996; 24: 35-46.
34. + T cell subsets during peripheral maturation in diabetes-prone BioBreeding rats. J. Immunol. 1996; 156: 1269-1275.
35. + T lymphocytes induces diabetes in resistant BioBreeding/ Worcester (BB/W) rats. J. Exp. Med. 1987; 166: 461-475.
36. A.A. Like, C.A. Biron, E.J. Weringer, K. Byman, E. Sroczynski and D.L. Guberski. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J. Exp. Med. 1986; 164: 1145-1159.
37. B.A. Woda, E.S. Handler, D.L. Greiner, C. Reynolds, J.P. Mordes and A.A. Rossini. T lymphocyte requirement for diabetes in RT6-depleted diabetes resistant BB rats. Diabetes 1991; 40: 423-428.
38. J.D. Jacobson, J.F. Markmann, K.L. Brayman, C.F. Barker and A. Naji. Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody. Diabetes 1988; 37: 838-841.
39. K.E. Ellerman, M. Wrobleski, A. Rabinovitch and A. Like. Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited). Diabetologia 1993; 36: 596-601.
40. - cells and high expression of the RT6 alloantigen. Eur. J. Immunol. 1991; 21: 753-760.
41. + cells in the rat. Am. J. Pathol. 1996; 148: 2043-2056.
42. J. Fangmann, R. Schwinzer, M. Winkler and K. Wonigeit. Expression of RT6 alloantigens and the T-cell receptor on intestinal intraepithelial lymphocytes of the rat. Transplant. Proc. 1990; 22: 2543-2544.